Clinical evaluation of TH-24, a newly synthetized xanthine derivative, in the treatment of the coronary artery disease.
D002316:Cardiotonic Agents; D003324:Coronary Artery Disease; D003327:Coronary Disease / Q000628:therapy*; D006801:Humans; D019820:Xanthine; D014970:Xanthines / Q000628:therapy*
D002316:Cardiotonic Agents; D014970:Xanthines; D019820:Xanthine
CORONARY DISEASE/therapy; XANTHINES/therapy